Advertisement
Document › Details
Stilla Technologies SAS. (2/2/21). "Press Release: Stilla Expands Leadership Team to Drive Next Phase of Global Commercial Growth; Appoints Philippe Mourere as President and CEO and Founder Rémi Dangla as CTO". Boston, MA & Paris.
Stilla Technologies is pleased to announce the appointment of Mr. Philippe Mourere as its new Chief Executive Officer. Former CEO and Founder Dr. Rémi Dangla has been appointed Chief Technology Officer and remains a member of the Board of Directors.
Stilla technologies was founded in 2013 and is a global leader in the digital PCR market. Its naica® product line includes the naica® system, microfluidic chips and reagents optimized for a wide variety of applications including liquid biopsy and COVID-19 testing. The appointment of Mr. Philippe Mourere represents a milestone in the company’s commercial evolution.
“We founded Stilla Technologies with the goal of improving healthcare by developing and providing solutions for high precision genetic analysis to researchers and clinicians worldwide. As we accelerate our commercial growth, I am pleased to be handing over the company’s leadership to Philippe who brings valuable experience for our next chapter,” commented Rémi Dangla. “I remain committed to driving the company’s innovations as Chief Technology Officer and a member of the Board of Directors.”
Mourere is an experienced executive leader with over 25 years’ experience gained at leading life science and diagnostic companies including HalioDx, Ultivue, Cell Signaling Technology, PerkinElmer and Caliper Life Sciences. Mourere has delivered transformative growth across genomic and proteomic market spaces globally.
“I am truly honored to join Stilla as President and CEO to build upon its strong foundation in the digital PCR market.” Mourere added “I am very impressed by the level of performance achieved by end users of Stilla’s platform across a wide range of applications. I look forward to working with Rémi and the team to continue to deliver highly differentiated solutions for critical applications.”
Nick Naclerio, Chairman of the Board, said,“On behalf of the Board of Directors, I want to recognize the accomplishments of Rémi Dangla as CEO through the past seven years and welcome Philippe Mourere as Stilla’s next Chief Executive Officer. Philippe’s vision and commercial experience is exactly what the company needs for its next phase of global growth.”
About Stilla Technologies
Stilla Technologies is a Paris-headquartered life sciences company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the naica® system. Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity for all areas of the life sciences. Stilla actively advises and supports its customers worldwide through its dynamic and multidisciplinary R&D team, with expertise spanning from microfluidics to chemistry, including molecularbiology and AI.
Record changed: 2024-03-30 |
Advertisement
More documents for Stilla Technologies (Group)
- [1] Stilla Technologies SAS. (2/22/24). "Press Release: Stilla Technologies Closes $26.5M Series C Financing to Accelerate Commercialization of Its Digital PCR Platform – Expands Leadership team". Paris & Boston, MA....
- [2] Johnson, Madeleine [GenomeWeb]. (11/16/23). "News: Stilla Focuses on Ease of Use With New Seven-Channel Digital PCR System". New York, NY....
- [3] Stilla Technologies SAS. (11/23/21). "Press Release: Stilla Technologies Secures Financing of more than €31 Million Adding Casdin Capital and the European Investment Bank to Existing Investors". Paris & Boston, MA....
- [4] Stilla Technologies SAS. (6/30/21). "Press Release: Stilla Technologies Strengthens Executive Team with Appointment of Matthew Grow, PhD, to Vice President Global Marketing and Commercial Operations". Boston, MA & Paris....
- [5] Stilla Technologies SAS. (2/11/20). "Press Release: Stilla Technologies Raises €20 Million ($22 Million) in Series B Round that Brings in New Investor, TUS-Holdings, alongside Existing Ones". Paris....
- [6] Coulter Partners. (1/28/20). "Press Release: Coulter Partners Secures Chief Financial Officer for Stilla Technologies"....
- [7] Stilla Technologies SAS. (12/10/19). "Press Release: Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution". Paris....
- [8] Stilla Technologies SAS. (10/10/19). "Press Release: Stilla Technologies Opens U.S. Subsidiary for Direct Commercial Operations Under the Leadership of Life Science Veteran". Beverly, MA....
- [9] Stilla Technologies SAS. (5/2/19). "Press Release: Renowned Digital PCR Experts at Ghent University Join Hands with Stilla Technologies to Expand the Frontiers of Crystal dPCR Using the Naica System". Ghent & Villejuif....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top